Phio Pharmaceuticals Corp.

US$0.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PHIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (67.82%)
Div yield —
ROE (158.97%)
Biotechnology
Beta (5Y) 0.92
PE TTM —
TSR TTM (60.91%)
Mkt cap US$9.309M
ROIC (103.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.957
19.47%
6.49%
Hold 6|4|2|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
15.41%
7.85%
11.66%
11.15%
Revenue$M
0.618
0.601
0.597
0.589
7.92%
0.43%
0.18%
0.41%
Peers (US$9.309M)
Cap (US$)
PE
9.421M
—
9.286M
—
9.314M
2.652x
Capital
TTM
5Y
10Y
Leveragex
9.365
(0.246)
(0.171)
EBIT/Intx
1.376
1.310
1.424
Own earn%
(5.20)
(109.07)
(89.68)
Sh yield%
12.47
49.95
49.84
Owners
Insiders/Inst%
14.59
85.48
Short interest%
3.54
SBC / revenue%
0.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
4–13
$1 testx
0.2
Incr. ROIC%
4